Lupin announces Patent License Agreement with Abbott


Today Lupin announced that it and its subsidiaries, Lupin Pharmaceuticals, Inc and Lupin Atlantis Holding S.A., have entered into a license agreement with Abbott Laboratories and Laboratoires Fournier S.A. for various Abbott patents for Antara® (Fenofibrate) Capsules. The licensed patents include, collectively, U.S. Patent Nos. 4,895,726; 6,074,670; 6,277,405; 6,589,552; 7,037,529; 7,041,319; 6,596,317; and 6,652,881; and any divisionals, continuations, continuations in part, reissues, reexaminations, and extensions thereof.

[RTT News]

Note: Lupin sued Ranbaxy recently for Antara.

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news, Patent case. Bookmark the permalink.

1 Response to Lupin announces Patent License Agreement with Abbott

  1. Shyam says:

    Time to go bottom-fishing with Lupin? What is the company upto?

Leave a Reply to Shyam Cancel reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s